Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
Public ClinicalTrials.gov record NCT07637942. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase IV Study of the Pharmacokinetics of Long-Acting Injectable Cabotegravir and Rilpivirine in Pregnant and Postpartum Women With HIV in the United States
Study identification
- NCT ID
- NCT07637942
- Recruitment status
- Not yet recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- International Maternal Pediatric Adolescent AIDS Clinical Trials Group
- Network
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Interventions
- Every 4-week long-acting injectable cabotegravir and rilpivirine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 14, 2026
- Primary completion
- Feb 14, 2028
- Completion
- Feb 14, 2028
- Last update posted
- Jun 9, 2026
2026 – 2028
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 4601, University of California, UC San Diego CRS | La Jolla | California | 92093 | — |
| Site 5048, University of Southern California | Los Angeles | California | 90033 | — |
| Site 5052, University of Colorado | Aurora | Colorado | 80045 | — |
| Site 5030, Emory University School of Medicine | Atlanta | Georgia | 30322 | — |
| Site 4001, Lurie Children's Hospital of Chicago CRS | Chicago | Illinois | 60614 | — |
| Site 5092, Johns Hopkins University | Baltimore | Maryland | 21287 | — |
| Site 5013, Jacobi Medical Center Bronx | The Bronx | New York | 10461 | — |
| Site 6201, University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Site 6501, St Jude Children's Research Hospital | Memphis | Tennessee | 38105 | — |
| Site 5128, Baylor College of Medicine/Texas Children's Hospital | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07637942, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 9, 2026 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07637942 live on ClinicalTrials.gov.